Strata Skin Sciences, Inc.
SSKN
$0.14
$0.014.37%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.70M | 30.98M | 32.85M | 33.62M | 33.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.70M | 30.98M | 32.85M | 33.62M | 33.56M |
| Cost of Revenue | 12.95M | 13.08M | 13.85M | 13.95M | 14.46M |
| Gross Profit | 17.75M | 17.90M | 19.00M | 19.67M | 19.11M |
| SG&A Expenses | 23.39M | 23.46M | 24.24M | 23.06M | 23.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.14M | -- | -- | -- | -- |
| Total Operating Expenses | 44.88M | 37.09M | 38.71M | 37.74M | 38.56M |
| Operating Income | -4.89M | -6.11M | -5.86M | -4.12M | -5.00M |
| Income Before Tax | -6.47M | -11.27M | -11.72M | -9.33M | -10.27M |
| Income Tax Expenses | 12.00K | -170.00K | -170.00K | -170.00K | -170.00K |
| Earnings from Continuing Operations | -6.49 | -11.10 | -11.55 | -9.16 | -10.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.49M | -11.10M | -11.55M | -9.16M | -10.10M |
| EBIT | -4.89M | -6.11M | -5.86M | -4.12M | -5.00M |
| EBITDA | 57.00K | -1.58M | -954.00K | 816.00K | -29.00K |
| EPS Basic | -1.53 | -2.63 | -2.78 | -2.22 | -2.59 |
| Normalized Basic EPS | -1.02 | -1.13 | -1.13 | -0.93 | -1.16 |
| EPS Diluted | -1.52 | -2.63 | -2.78 | -2.22 | -2.59 |
| Normalized Diluted EPS | -1.02 | -1.13 | -1.13 | -0.93 | -1.16 |
| Average Basic Shares Outstanding | 18.60M | 17.00M | 16.56M | 15.89M | 15.22M |
| Average Diluted Shares Outstanding | 18.60M | 17.00M | 16.56M | 15.89M | 15.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |